HighTower Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
HighTower Advisors's ABMD Position: Q4 2022 in Review
HighTower Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 13,014 shares — an estimated $3.15M sold.
HighTower Advisors first reported a position in ABMD in Q2 2018 and held it in 17 quarters. The position peaked at $4.28M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- HighTower Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- HighTower Advisors sold 13,014 Abiomed Inc shares in Q4 2022, an estimated $3.15M.
- HighTower Advisors first reported a position in Abiomed Inc in Q2 2018 and held it in 17 quarters.
- HighTower Advisors's Abiomed Inc position peaked at $4.28M in Q4 2021.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.